Jemperli gets expanded access

By Megan Brodie 1 year ago | In Products, Regulatory
  • 1 year ago

5 May 2025 GSK Australia’s immune therapy JEMPERLI (dostarlimab) has been expanded by the TGA…

This is subscriber-only content. Please login to continue reading.

Recent News

Top Reads